Novo Nordisk’s slower growth will crimp employee bonuses in the Ozempic maker’s... EU tariffs on Russian fertiliser imports that aim to cut funding for Moscow's war ...

These were among the concerns of a recent regulatory inspection of a key, but historically troubled, manufacturing plant that ...

Whether it’s a cook, a home health aide, or a direct support professional, domestic workers are critical for so many people ...

Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated ...

Novo Nordisk (NVO) will be forced to lower employee bonuses in its home country, Denmark, as the company doubles down on a cost-cutting drive following a cut to its growth outlook this year, Bloomberg ...